Carrie Lachance Purchases 2,000 Shares of InfuSystem (NYSE:INFU) Stock

InfuSystem Holdings, Inc. (NYSE:INFU) CEO Carrie Lachance purchased 2,000 shares of the firm’s stock in a transaction dated Friday, May 8th. The stock was bought at an average cost of $8.83 per share, for a total transaction of $17,660.00. Following the acquisition, the chief executive officer directly owned 237,123 shares in the company, valued at approximately $2,093,796.09. The trade was a 0.85% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.

Carrie Lachance also recently made the following trade(s):

• On Monday, May 11th, Carrie Lachance purchased 1,000 shares of InfuSystem stock. The stock was bought at an average cost of $8.46 per share, for a total transaction of $8,460.00.

InfuSystem Price Performance

Shares of NYSE:INFU opened at $8.21 on Thursday. The company’s fifty day moving average price is $9.64 and its 200-day moving average price is $9.19. The firm has a market capitalization of $165.79 million, a price-to-earnings ratio of 136.86 and a beta of 1.49. InfuSystem Holdings, Inc. has a one year low of $5.08 and a one year high of $11.04. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59.

Hedge Funds Weigh In On InfuSystem

A number of institutional investors have recently made changes to their positions in the stock. Minerva Advisors LLC boosted its stake in shares of InfuSystem by 5.2% in the 4th quarter. Minerva Advisors LLC now owns 1,078,731 shares of the company’s stock valued at $9,676,000 after purchasing an additional 52,942 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of InfuSystem by 1.9% in the 3rd quarter. Vanguard Group Inc. now owns 976,177 shares of the company’s stock valued at $10,113,000 after purchasing an additional 18,539 shares in the last quarter. Punch & Associates Investment Management Inc. boosted its stake in shares of InfuSystem by 1.9% in the 4th quarter. Punch & Associates Investment Management Inc. now owns 824,750 shares of the company’s stock valued at $7,398,000 after purchasing an additional 15,000 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of InfuSystem by 6.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 594,288 shares of the company’s stock valued at $5,486,000 after purchasing an additional 33,410 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its stake in shares of InfuSystem by 2.0% in the 4th quarter. Renaissance Technologies LLC now owns 587,509 shares of the company’s stock valued at $5,270,000 after purchasing an additional 11,795 shares in the last quarter. Institutional investors own 71.13% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Roth Mkm reissued a “buy” rating and issued a $15.00 price target (up from $14.00) on shares of InfuSystem in a report on Tuesday, February 24th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $15.00.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.